Market Overview

Why Eli Lilly's Stock Is Trading Higher Today

Why Eli Lilly's Stock Is Trading Higher Today

Eli Lilly (NYSE: LLY) shares are trading higher on Monday after the company initiated a Phase 3 trial of LY-CoV555 for the prevention of COVID-19 at long-term care facilities in partnership with the NIAID.

Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Forteo for osteoporosis; Jardiance, Trulicity, Humalog, and Humulin for diabetes; Taltz and Olumiant for immunology; and Cialis for erectile dysfunction.

Eli Lilly shares were trading up 1.30% to $152.24 at time of publication on Monday. The stock has a 52-week high of $170.75 and a 52-week low of $101.36.


Related Articles (LLY)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Health Care General